Newest Release Improves Access to Care, Enhances Cancer Patient Experience, Increases Efficiency, and Boosts Patient Retention

Azra AI Expands Capabilities of Its Trusted, Industry-Leading End-to-End Oncology Platform

Jason Beck
Chief Marketing Officer
Azra AI
Email: jason.beck@azra-ai.com

Azra AI, a healthtech leader harnessing artificial intelligence (AI) and workflow automation to accelerate can cer identification and treatment, today announced new enhancements to its trusted end-to-end oncology platform, used by hundreds of healthcare organizations. The newest release, which will be showcased at the upcoming Association of Cancer Executives (ACE) Annual Meeting and ViVE healthcare event, makes it easier to create personalized cancer treatment plans, streamline care coordination and navigation, and gain actionable, real-time insights into service line performance.

According to research from the American Cancer Society, over two million new cancer cases are expected in 2025, which roughly translates to over 5,500 new cancer diagnoses every day. “With cancer rates on the rise, health systems face mounting pressure to move beyond inefficient, manual processes,” said John Marshall, CEO of Azra AI. “Our platform addresses these challenges by equipping oncology teams with advanced technology that automates critical oncology workflows throughout the entire oncology service line — all while eliminating the complexity and inefficiencies of fragmented point solutions. Ultimately, we empower care teams to focus on what matters most: delivering exceptional, patient-centered care.”

Azra AI’s platform redefines oncology care with the only end-to-end solution, supporting the full continuum of care—from suspicion to survivorship. At its core, advanced AI models trained on over 100 million pathology and radiology reports power Azra AI’s platform, developed through an exclusive partnership with one of the largest leading U.S. health systems.

The Pathology AI models identify newly diagnosed cancer patients with unmatched precision, surfacing cases by primary site, stage, tumor markers, and other clinical characteristics. The Radiology AI models detect suspicious incidental findings across lung, pancreas, liver, ovarian and endometrial, colon, neuro, and more—prioritizing high-risk findings that might otherwise go unnoticed. Azra also structures unstructured data from cancer screens to ensure patients receive necessary follow-up.

Azra’s platform applies these insights across its key workflow automation modules that enhance oncology care and improve operational efficiency, including:

• Compass™ – Tumor Board Module: Streamlines preparation and data collection for multidisciplinary meetings, enabling faster, evidence-based decisions.
• Journey™ – Care Coordination and Navigation Module: Allows navigators to track patient care, prioritize outreach, and update EHRs in real-time, replacing manual documentation processes.
• Flow™ – Cancer Registry Automation Module: Automates manual case finding and integrates data seamlessly into any registry database, improving compliance and efficiency.

The latest release introduces expanded capabilities in existing modules and a new analytics module, Azra IQ™:

• Compass™: Enhancements streamline case preparation, centralize patient data, and ensure compliance with accreditation standards.
• Journey™: New features include:
  • Distress Screening: Identifies and addresses barriers like transportation, financial concerns, and emotional distress early in the patient journey, fostering equitable access to care and improved outcomes.
  • Navigation Reimbursement: Seamlessly bill for navigation services, under the latest CMS guidelines. Azra ensures all required elements are met and tracked, allowing health systems to benefit from navigation services if desired.
• Azra IQ™ – Real-Time Data & Analytics Module: Customizable dashboards provide insights into patient volumes, referral patterns, barriers to care, and more—delivering actionable insights that fragmented systems cannot achieve. By eliminating silos and ensuring accurate, comprehensive data, health systems can optimize resources, identify growth opportunities, and enhance overall impact.

"Oncology service lines need proven technology to run smoothly. Dealing with multiple vendors to piece together that technology is a headache for IT and a pain for users—it just doesn’t work long-term," said Marshall. "That kind of patchwork approach is messy, expensive, and risky. At Azra, we built a single platform that takes care of it all, and that’s a big reason why we’re seeing so much success and healthcare organizations are seeing greater positive impact."

About Azra AI

Azra AI is a healthtech firm transforming healthcare with the industry’s only end-to-end oncology service line platform. Our solution analyzes pathology and radiology reports in real-time to identify cancer diagnoses and high-risk findings, enabling caregivers to connect patients to treatment sooner and manage their care journey—all within a single platform. Learn more or schedule a demo at www.azra-ai.com/get-a-demo.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250121681603/en/